Trial intelligence / Profile preview

I-131 Iodocholesterol for Adrenal Screening

NCT00037843Phase 3Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Dec 1988
Primary completion
Aug 2007
Modality
Radiopharmaceutical
Countries
1
01

Overview

A Phase 3 trial of iodine (131I) norcholesterol in adrenal gland disorders, adrenal gland neoplasms, sponsored by University of Texas MD Anderson Cancer Center. Started Dec 1988; status: completed.

02

Drugs

iodine (131I) norcholesterol
03

Conditions

adrenal gland disordersadrenal gland neoplasms

Beyond the preview

Go deeper on NCT00037843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00037843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call